|
Mr. Curaudeau comes to QLT with extensive global experience in pharmaceutical research and development after serving more than 15 years with Rhone-Poulenc Rorer (RPR), a major international pharmaceutical company. His tenure with RPR included 14 years of progressively senior positions in project management, in France and in the U.S. Most recently he was designated head of Project Management for Aventis, a new company formed in 1999 by the merger between RPR and Hoechst AG.
Mr. Curaudeau holds a Masters of Science degree in Pharmaceutical Sciences from the University of Chatenay-Malabry, Paris, France. He is also a graduate of the Toxicology and Pharmacokinetics Programs from the same university and received academic training in toxicological pathology from the National Veterinary School in Toulouse, France. | 